Pravastatin for Cardiovascular Event Primary Prevention in Patients With Mild-to-Moderate Hypertension in the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study

No abstract is available for this paper.

• Publication year

  2009

• Venue

  HYPERTENSION

• Publication date

  2009-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/HYPERTENSIONAHA.108.120584PMID 19104004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estimation of treatment effect adjusting for treatment changes using the intensity score method: Application to a large primary prevention study for coronary events (MEGA study)

  2008cited by this paper
• Lipid levels and the risk of ischemic stroke in women

  2007cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

  2007cited by this paper
• Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial.

  2006cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

  2005cited by this paper
• Clinical characteristics of first-ever atherothrombotic infarction or lacunar infarction with hyperlipidemia (J-STARS-C): an analysis of data from the stroke data bank of Japan.

  2005cited by this paper
• Different time course for prevention of coronary and stroke events by atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA).

  2005cited by this paper
• Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

  2004cited by this paper
• Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes.

  2004cited by this paper
• Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.

  2004cited by this paper
• Design and baseline characteristics of a study of primary prevention of coronary events with pravastatin among Japanese with mildly elevated cholesterol levels.

  2004cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial.

  2002cited by this paper
• Reduction of Stroke Events With Pravastatin: The Prospective Pravastatin Pooling (PPP) Project

  2001cited by this paper
• HDL-Cholesterol, total cholesterol, and the risk of stroke in middle-aged British men.

  2000cited by this paper
• Risk stratification in hypertension: new insights from the Framingham Study.

  2000cited by this paper
• Pravastatin therapy and the risk of stroke.

  2000cited by this paper
• Pravastatin therapy and the risk of stroke.

  2000cited by this paper
• PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA

  2000cited by this paper
• The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk.

  1999cited by this paper
• Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators.

  1999cited by this paper
• Incidence and risk factors for stroke in an occupational cohort: the PROCAM Study. Prospective Cardiovascular Muenster Study.

  1998cited by this paper
• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

  1998cited by this paper
• Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials.

  1998cited by this paper
• Incidence and Risk Factors for Stroke in an Occupational Cohort The PROCAM Study

  1998cited by this paper
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

  1998cited by this paper
• Reductase inhibitor monotherapy and stroke prevention.

  1997cited by this paper
• Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials.

  1997cited by this paper
• The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.

  1997cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

  1995cited by this paper
• Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration.

  1995cited by this paper
• The Impact of Alcohol and Hypertension on Stroke Incidence in a General Japanese Population

  1995cited by this paper
• The impact of alcohol and hypertension on stroke incidence in a general Japanese population. The Hisayama Study.

  1995cited by this paper
• Stroke in the diabetic patient.

  1994cited by this paper
• Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease.

  1994cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Risk factors for death from different types of stroke. Multiple Risk Factor Intervention Trial Research Group.

  1993cited by this paper

• The Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025)

  2026cites this paper
• Explaining adverse cholesterol levels and distinct gender patterns in an Indonesian population compared with the U.S.

  2024cites this paper
• Statins As Anti-Hypertensive Therapy: A Systematic Review and Meta-Analysis

  2024cites this paper
• Statin's role on blood pressure levels: Meta‐analysis based on randomized controlled trials

  2023cites this paper
• Effect of Combined Statin and Antihypertensive Therapy in Patients with Hypertension: A Systematic Review and Meta-Analysis

  2020cites this paper
• Treatment patterns in hyperlipidaemia patients based on administrative claim databases in Japan.

  2018cites this paper
• A Multi-Center, Open-Label, Two-Arm Parallel Group Non-inferiority Randomized Controlled Trial Evaluating the Effect of Pitavastatin, Compared to Atorvastatin, on Glucose Metabolism in Prediabetics with Hypertension and Dyslipidemia: Rationale and Design for the China Hemoglobin A1c Metabolism Prote

  2018cites this paper
• Usefulness of a healthcare database for epidemiological research in atrial fibrillation.

  2017cites this paper
• Stability Indicating HPLC Method for the Simultaneous Quantification of Aspirin and Pravastatin in bulk and Tablets : Method Development and Validation

  2017cites this paper
• Statin Use for the Prevention of Cardiovascular Disease in Adults: A Systematic Review for the U.S. Preventive Services Task Force

  2016cites this paper
• Comparison of lipid parameters to predict cardiovascular events in Japanese mild-to-moderate hypercholesterolemic patients with and without type 2 diabetes: Subanalysis of the MEGA study.

  2016cites this paper
• The effects of red yeast rice dietary supplement on blood pressure, lipid profile, and C-reactive protein in hypertension: A systematic review

  2015cites this paper
• Efficacy and Safety of a Traditional Chinese Herbal Formula Xuefu Zhuyu Decoction for Hypertension

  2015cites this paper
• The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study

  2015cites this paper
• Dietary modulators of statin efficacy in cardiovascular disease and cognition.

  2014cites this paper
• Blood pressure, low-density lipoprotein cholesterol, and incidences of coronary artery disease and ischemic stroke in Japanese: the Suita study.

  2014cites this paper
• [Neurological common diseases in the super-elder society. Topics: II. Stroke: 1. Risk factor control for preventing stroke].

  2014cites this paper
• Statins for the primary prevention of cardiovascular disease.

  2013cites this paper
• Antihypertensive Effects of Statins: A Meta‐Analysis of Prospective Controlled Studies

  2013cites this paper
• Rationale, design, and baseline features of a randomized controlled trial to assess the effects of statin for the secondary prevention of stroke: the Japan Statin Treatment Against Recurrent Stroke (J-STARS)

  2013cites this paper
• Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies

  2013cites this paper
• Blood pressure control status and effects of pravastatin on cardiovascular events occurrence in patients with dyslipidaemia

  2012cites this paper
• Rationale, study design, baseline characteristics and blood pressure at 16 weeks in the HONEST Study

  2012cites this paper
• 日本総合健診医学会 第39回大会・教育講演3 健診で循環器疾患を予防できるか

  2011cites this paper
• Intravenous administration of pravastatin immediately after middle cerebral artery occlusion reduces cerebral oedema in spontaneously hypertensive rats.

  2011cites this paper
• Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.

  2011cites this paper
• Administration of L-carnitine and mildronate improves endothelial function and decreases mortality in hypertensive Dahl rats

  2011cites this paper
• Ethnic variations in lipid-lowering in response to a statin (EVIREST): a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).

  2011cites this paper
• Prevention of atherosclerosis in overweight/obese patients. - In need of novel multi-targeted approaches-.

  2011cites this paper
• Statins for the primary prevention of cardiovascular disease (Review)

  2011cites this paper
• Prevention of Atherosclerosis in Overweight/Obese Patients

  2011cites this paper
• Undertreatment of hypercholesterolemia

  2010cites this paper
• Editorial commentary Undertreatment of hypercholesterolemia

  2010cites this paper
• Pravastatin for Cardiovascular Event Primary Prevention in Patients With Mild-to-Moderate Hypertension in the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study

  2010cites this paper
• Current role of statins in the treatment of essential hypertension

  2010cites this paper
• Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interaction.

  2010cites this paper
• 日本発の大規模臨床試験（MEGA Study）から得られた新たな知見

  2009cites this paper
• When statin therapy stops: implications for the patient

  2009cites this paper
• Additive beneficial effects of amlodipine and atorvastatin in reversing advanced cardiac hypertrophy in elderly spontaneously hypertensive rats

  2009cites this paper
• Safety and efficacy of statins in Asians.

  2007cites this paper
• Combination treatment to prevent atherosclerosis.

  2007cites this paper